CG Oncology
CGON
CGON
142 hedge funds and large institutions have $1.74B invested in CG Oncology in 2025 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 61 increasing their positions, 34 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
142
Holders Change
+2
Holders Change %
+1.43%
% of All Funds
1.93%
Holding in Top 10
10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-16.67%
% of All Funds
0.14%
New
27
Increased
61
Reduced
34
Closed
24
Calls
$1.15M
Puts
$859K
Net Calls
+$289K
Net Calls Change
-$5.17M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$33.3M |
| 2 |
O
OrbiMed
New York
|
+$25.5M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$23.5M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$16.9M |
| 5 |
Millennium Management
New York
|
+$8.5M |
Top Sellers
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$20.1M |
| 2 |
PA
Perceptive Advisors
New York
|
-$12M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.74M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$5.68M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$5.49M |
